Seroprevalence of Hepatitis E Virus Among Schistosomiasis mansoni Patients Residing in Endemic Zone in Brazil

The occurrence of hepatitis E virus (HEV) in patients with Schistosomiasis mansoni (SM) is still poorly understood in Brazil. The objective of this study was to estimate the seroprevalence of anti-HEV IgG in patients with SM and its association with the periportal fibrosis (PPF), assessed by serum m...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristiane Tiburtino de Oliveira Gomes, Carolline Araujo Mariz, Andrea Dória Batista, Clarice Neuenschwander Lins de Morais, Lílian Araújo, Ana Virgínia Matos Sá Barreto, Michele Soares Gomes-Gouvêa, Ana Lúcia Domingues, Edmundo Pessoa Lopes
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Tropical Medicine and Infectious Disease
Subjects:
Online Access:https://www.mdpi.com/2414-6366/9/12/310
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The occurrence of hepatitis E virus (HEV) in patients with Schistosomiasis mansoni (SM) is still poorly understood in Brazil. The objective of this study was to estimate the seroprevalence of anti-HEV IgG in patients with SM and its association with the periportal fibrosis (PPF), assessed by serum markers and ultrasound criteria. This cross-sectional study was carried out in an endemic area in Pernambuco, Brazil, with schistosomal patients who underwent coproscopic survey. Anti-HEV antibody IgG were evaluated by using ELISA (Euroimmun<sup>®,</sup> Lübeck, Germmany). In positive cases, HEV-RNA was tested by using real-time PCR. Among the 286 patients (60.8% women; 56% 18–44 years), 116 (40.6%) had advanced PPF (Niamey pattern D/E/F). Anti-HEV IgG was positive in 15 (5.24%), and all were HEV-RNA negative. Anti-HEV IgG was more frequent in patients with an advanced PPF (D/E/F) pattern (<i>p</i> = 0.034) and those with the largest spleen diameter (<i>p</i> = 0.039). In this study, the occurrence of anti-HEV IgG in patients with SM was higher than described in the same region and more frequent among patients with evidence of advanced liver fibrosis.
ISSN:2414-6366